SCIENTECH (02291) spent 412,400 Hong Kong dollars to repurchase 38,000 shares on July 16th.
Heartai Medical (02291) announced that it repurchased 38,000 shares for a total of HKD 412,400 on July 16, 2026.
SCIENTECH (02291) announces that it will spend 412,400 Hong Kong dollars to repurchase 38,000 shares on July 16, 2026.
Related Articles
CSPC PHARMA (01093): The Phase III clinical trial of SYS 6043 for the treatment of platinum-resistant advanced ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has officially started at the first center in China.
Inner Mongolia Xingye Silver & Tin Mining (000426.SZ) subsidiary plans to subscribe for 20% of the shares of the Australian listed company TAT.
Step out of the shadow of historic collapse! UnitedHealth Group Incorporated (UNH.US) significantly raises full-year guidance, blowing the horn of recovery with better-than-expected financial report.
CSPC PHARMA (01093): The Phase III clinical trial of SYS 6043 for the treatment of platinum-resistant advanced ovarian cancer, primary peritoneal cancer, and fallopian tube cancer has officially started at the first center in China.
Inner Mongolia Xingye Silver & Tin Mining (000426.SZ) subsidiary plans to subscribe for 20% of the shares of the Australian listed company TAT.
Step out of the shadow of historic collapse! UnitedHealth Group Incorporated (UNH.US) significantly raises full-year guidance, blowing the horn of recovery with better-than-expected financial report.
RECOMMEND
